(NP (NP (NP (DT A) (JJ nuclear) (NN factor) (NN NF-GM2)) (SBAR (WHNP-105 (WDT that)) (S (NP-SBJ (-NONE- *T*-105)) (VP (VBZ interacts) (PP (IN with) (NP (NP (DT a) (JJ regulatory) (NN region)) (PP (IN of) (NP (NP (DT the) (NN GM-CSF) (NN gene)) (ADJP (JJ essential) (PP (IN for) (NP (PRP$ its) (NN induction))) (PP (IN in) (NNS responses) (TO to) (NP (NN T-cell) (NN activation))))))))))) (: :)) (NP (NP (NP (NN purification)) (PP (IN from) (NP (JJ human) (NN T-cell) (NN leukemia) (NN line) (NN Jurkat) (NNS cells)))) (CC and) (NP (NP (NN similarity)) (PP (TO to) (NP (NN NF-kappa) (NN B)))) (. .)))
(S (NP-SBJ (NP (NN Activation)) (PP (IN of) (NP (NN T) (NNS cells))) (PP (IN by) (NP-COOD (NP (NN antigen)) (, ,) (NP (NN lectin)) (, ,) (CC or) (NP (NP (DT a) (NN combination)) (PP (IN of) (NP-COOD (NP (NP (NN phorbol-12-myristate) (NN acetate)) (PRN (-LRB- -LRB-) (NP (NN PMA)) (-RRB- -RRB-))) (CC and) (NP (NP (NN calcium) (NN ionophore)) (PRN (-LRB- -LRB-) (NP (NN A23187)) (-RRB- -RRB-))))))))) (VP (VBZ leads) (PP (TO to) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NP (NNS genes)) (PP (IN for) (NP (NP (DT a) (NN set)) (PP (IN of) (NP (NP (NNS lymphokines)) (, ,) (PP (VBG including) (NP (NP (ADJP (JJ granulocyte-macrophage) (JJ colony-stimulating)) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN GM-CSF)) (-RRB- -RRB-))))))))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBD demonstrated) (PP (IN in) (NP (JJR earlier) (NNS studies))) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (JJ upstream) (NN region)) (PP (IN of) (NP (DT the) (NN mouse) (NN GM-CSF) (NN promoter))) (PP (IN at) (NP (NP (NNS positions)) (PP (IN between) (NP-COOD (NP (CD -95)) (CC and) (NP (CD -73))))))) (VP (VBZ is) (ADJP-PRD (JJ essential) (PP (IN for) (NP (NP (JJ transcriptional) (NN activation)) (PP (IN in) (NN response) (TO to) (NP (NN (A23187 PMA))))))))))) (. .))
(S (NP-SBJ (DT This) (NN region)) (VP (VBZ contains) (NP (NP (CD two) (JJ DNA-binding) (NNS motifs)) (, ,) (NP-COOD (NP (NN GM2)) (CC and) (NP (NN GC-box))))) (. .))
(S-COOD (S (NP-SBJ-107 (NP (DT The) (NN GM2) (NN sequence)) (PRN (-LRB- -LRB-) (NP (NN GGTAGTTCCC)) (-RRB- -RRB-))) (VP (VBZ is) (VP (VBN recognized) (NP (-NONE- *-107)) (PP-108 (IN by) (NP-LGS (DT an) (JJ inducible) (NN factor) (NN NF-GM2)))))) (: ;) (S (NP-SBJ=107 (NP (DT the) (JJ other)) (PRN (-LRB- -LRB-) (NP (NN CCGCCC)) (-RRB- -RRB-))) (VP (PP=108 (IN by) (NP-LGS (JJ constitutive) (NNS factors) (NP-COOD (NP (NN A1)) (, ,) (NP (NN A2)) (, ,) (CC and) (NP (NN B))))))) (. .))
(S (S (NP-SBJ (-NONE- *-109)) (VP (TO To) (VP (VB elucidate) (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NN GM-CSF) (NN gene) (NN activation))))))) (, ,) (S (NP-SBJ-109 (PRP we)) (VP (VBP have) (VP (VBN purified) (NP (DT the) (JJ inducible) (NN factor) (NN NF-GM2)) (PP (IN from) (NP (NP (DT the) (JJ nuclear) (NN extract)) (PP (IN of) (NP (VBN stimulated) (NN Jurkat) (NNS cells))))) (PP (IN on) (DT the) (NN basis) (IN of) (NP (JJ specific) (JJ DNA-binding) (NN activity)))))) (. .))
(S (NP-SBJ (DT The) (VBN purified) (NN NF-GM2)) (VP-COOD (VP (VBZ consists) (PP (IN of) (NP (NP (NP-COOD (NP (NP (CD 50)) (PRN (-LRB- -LRB-) (NP (NN p50)) (-RRB- -RRB-))) (CC and) (NP (NP (CD 65)) (PRN (-NONE- *ICH*-21)))) (NN kDa)) (PRN-21 (-LRB- -LRB-) (NP (NN p65)) (-RRB- -RRB-)) (NNS polypeptides)))) (CC and) (VP (VBZ has) (NP (NP (DT a) (NN binding) (NN activity)) (ADJP (JJ specific) (PP (IN for) (NP (CC both) (DT the) (NP-COOD (NP (NN GM-CSF)) (CC and) (NP (NP (NN immunoglobulin) (NN kappa)) (PRN (-LRB- -LRB-) (NP (NN GGAAAGTCCC)) (-RRB- -RRB-)))) (NNS enhancers))))))) (. .))
(S-COOD (S (NP-SBJ (NP (ADJP (RB Electrophoretically) (VBN purified)) (NN p50)) (ADVP (RB alone))) (VP (MD can) (VP (VB form) (NP (DT a) (JJ protein-DNA) (NN complex))))) (, ,) (CC but) (S (PP (IN in) (NP (DT the) (NN mixture))) (, ,) (NP-SBJ-207 (NN p50)) (VP (VBZ associates) (ADVP (RB preferentially)) (PP (IN with) (NP (NN p65))) (S (NP-SBJ (-NONE- *-207)) (VP (TO to) (VP (VB form) (NP (DT the) (NN NF-GM2) (NN complex))))))) (. .))
(S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ (NN p65)) (VP (VBD gave) (ADVP (FW per) (FW se)) (, ,) (PP (IN with) (NP (JJ low) (NN affinity))) (, ,) (NP (NP (DT a) (JJ protein-DNA) (NN complex)) (SBAR (WHNP-208 (WDT that)) (S (NP-SBJ (-NONE- *T*-208)) (VP (VBD migrated) (ADVP (ADVP (RBR more) (RB slowly)) (PP (IN than) (NP (JJ native) (NN NF-GM2) (NN complex))))))))) (. .))
(S (ADVP (RB Furthermore)) (, ,) (NP-SBJ (NP (DT an) (NN antiserum)) (PP (IN against) (NP (NP (NN KBF1)) (PRN (-LRB- -LRB-) (ADJP (JJ identical) (PP (TO to) (NP (CD 50) (NN kDa) (NN NF-kappa) (NN B) (NN protein)))) (-RRB- -RRB-))))) (VP (VBD reacted) (PP (IN with) (NP (NP (DT the) (NN p50)) (PP (IN of) (NP (NN NF-GM2))))) (, ,) (S (NP-SBJ (-NONE- *)) (VP (VBG indicating) (SBAR (IN that) (S (NP-SBJ-209 (DT the) (NN NF-GM2) (NN polypeptide)) (VP (MD can) (RB not) (VP (VB be) (ADVP (RB immunologically)) (VP (VBN differentiated) (NP (-NONE- *-209)) (PP (IN from) (NP (NP (DT the) (CD 50) (NN kDa) (NN subunit)) (PP (IN of) (NP (NN NF-kappa) (NN B))))))))))))) (. .))
(S (NP-SBJ (DT The) (VBN purified) (NN NF-GM2)) (VP (VBD activated) (NP (NP (ADJP (FW in) (FW vitro)) (NN transcription)) (PP (IN from) (NP (DT the) (NN kappa) (NN B) (NN enhancer)))) (, ,) (SBAR (IN while) (S (NP-SBJ-210 (PRP it)) (VP (VBD failed) (S (NP-SBJ (-NONE- *-210)) (VP (TO to) (VP (VB stimulate) (NP (NP (NN transcription)) (PP (IN from) (NP (NP (DT the) (NN GM-CSF) (NN promoter)) (VP (VBG harboring) (NP (DT the) (NN GM2) (NN sequence))))))))))))) (. .))
(S (NP-SBJ (DT This)) (VP (VBZ suggests) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN activation) (NN mechanism)) (PP (IN of) (NP (DT the) (NN GM-CSF) (NN gene))) (PP (IN through) (NP (DT the) (JJ (GC-box GM2)) (NN sequence)))) (VP (VBZ is) (ADJP-PRD (JJ different) (PP (IN from) (NP (NP (DT that)) (PP (IN of) (NP (NP (NNS genes)) (VP (VBG carrying) (NP (NP (DT the) (NN kappa) (NN B) (NN enhancer)) (ADVP (RB alone))))))))))))) (. .))
